Beginning with high-purity reference standards, continuing with clinical-scale volume, and scaling up customers’ APIs following regulatory approval, Purisys assists customers at every phase of commercial development.
Purisys offers the most comprehensive portfolio of cannabinoid ingredients on the market today. Our cannabinoid offerings include:
• Cannabidiol (CBD)
• Dronabinol (THC)
• Cannabinoid Varins
• Cannabinoid Reference Standards
We manufacture these ingredients at high-capacity cGMP production facilities in Europe and the United States. In fact, we have the largest capacity for production of cannabinoids in the world today. If you are developing cannabinoid-based pharmaceuticals toward regulatory approval in more than one country or region, you can partner with Purisys for global supply solutions. cGMP production is in place in Europe and the United States, making export and import of your cannabinoid APIs to the country of your choice fast, secure and in regulatory compliance.
A Secure Cannabinoid Supply Chain
Pharmaceutical manufacturers that partner with Purisys get superior supply chain security. High-quality raw materials for the manufacture of cannabinoids is specifically dedicated at the start of any partnership, along with dedicated cannabinoids production capacity, and secure delivery of API in full compliance with DEA import and export rules. GMP manufacturing of CBD in the US and EMEA provides Purisys with true global reach to customers within a multitude of market sectors.